Dr Kola Tytler (MBBS MBA MRCGP) | 15 July 2026 | 9 min read
Every maturing technology category in the NHS tends to follow a similar arc: individual clinicians experimenting, then department-level pilots, then trust-wide deployment, then regional or ICB-level frameworks, and eventually integration into broader clinical workflow platforms rather than standalone tools. Ambient voice technology has now visibly reached the fourth stage. Heidi's reported Midlands framework, alongside Tandem's reported four-year, roughly 10,000-clinician NHS agreement, are the clearest evidence yet that regional procurement, not clinician adoption alone, is now shaping how this category grows.
Why regional procurement is emerging now
Regional frameworks reduce duplicated procurement effort across trusts that would otherwise each run their own tender for broadly similar functionality. They create common governance materials, meaning DPIAs, clinical safety documentation and patient information do not need to be redrafted from scratch at every site. They enable volume pricing that individual trusts cannot access alone. They support genuinely comparable regional evaluation, since sites are using the same product under similar terms. They create commercial leverage over integration work and service levels that a single trust rarely has on its own. And they particularly help smaller organisations that lack the digital and procurement capacity to run a full AVT tender independently.
Why being selected early matters commercially
For a supplier, early selection into a regional framework creates a large potential user pool without repeating the sales cycle fifteen times. It establishes reference deployments that carry weight with other NHS regions considering the same decision. It supports faster, larger-scale evidence generation than a single trust pilot ever could. It builds direct relationships with NHS regional leadership rather than only individual clinical champions. It encourages integration work with a regional EPR estate that then becomes genuinely difficult to unwind. And it opens the door to expansion into adjacent workflows, coding, referrals, decision support, once the core documentation relationship is established and trusted.
Why the Heidi framework is competitively significant
If it proceeds as reported, the Midlands framework gives Heidi a major institutional NHS story that counters any perception of it as primarily an individually adopted GP tool. It strengthens its position directly against Tandem's Accurx-enabled distribution and against TORTUS's NHS deployment and UKCA-first regulatory narrative. It creates a stronger institutional foundation to build future Class IIa positioning on. And it may reasonably encourage other NHS regions to pursue similar sole-supplier or preferred-supplier arrangements, accelerating the shift the whole category is already going through.
The genuine benefits of supplier competition
Competitive pressure between Heidi, Tandem, TORTUS and others entering the market is likely to produce better EPR integrations, stronger implementation support, more rigorous published evidence, greater regulatory clarity as suppliers race to demonstrate assurance rather than avoid it, more competitive pricing, faster feature development, more transparent safety reporting, and a sharper focus on clinician experience rather than only headline productivity claims.
The genuine risks of regional sole-supplier models
The same dynamic carries real risks worth naming plainly. Vendor lock-in becomes more likely once templates and integrations are deeply embedded. Regional organisations lose the ability to compare products through real-world parallel use once a sole supplier is selected. Dependence concentrates on one supplier's infrastructure and, by extension, its uptime and security posture. Switching becomes genuinely difficult once workflows are built around one product. Competitive pressure on that supplier eases for the duration of the contract. One product may not suit every specialty equally well, yet a sole-supplier framework offers little room to reflect that. And operational and cybersecurity risk becomes concentrated in a single vendor relationship across a large regional footprint.
Interoperability questions worth asking before signing
Before committing to a regional or sole-supplier arrangement, organisations should ask whether templates can be exported if the contract ends, whether structured data can be transferred to a different vendor, whether locally configured workflows can be retained through a switch, whether audit data remains available after contract termination, whether a trust can change supplier without rebuilding every integration from scratch, and whether more than one AVT product can realistically operate safely within the same region during a transition period.
The likely next phase of competition
Basic documentation is becoming commoditised across the category faster than most suppliers publicly acknowledge. The next contest is more likely to play out in clinical coding, letters, orders and referrals, clinical decision support, evidence retrieval at the point of care, workflow automation, and the ability to carry longitudinal patient context across encounters rather than treating each consultation in isolation. Differentiation is likely to shift further towards integration quality and implementation support rather than raw transcription accuracy, which is converging across the category. More suppliers are likely to pursue higher medical device certification as functionality expands, and buyers should expect increasing scrutiny of whether every advertised feature actually sits within a supplier's certified scope, rather than assuming the whole product inherits the certification of its most regulated component.
Conclusion
Heidi's Midlands framework, whatever its final scope turns out to be, is evidence that the NHS AVT market is moving from clinician-led experimentation towards regional infrastructure. The next contest between these suppliers will not simply be about who writes the best consultation note. It will be about which of them can combine regulation, integration, evidence, implementation quality, genuine interoperability and sustainable commercial terms, sustained across years rather than a single procurement cycle.